KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE – Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 258,682 shares, a decline of 43.2% from the September 30th total of 455,237 shares. Based on an average daily volume of 145,143 shares, the days-to-cover ratio is currently 1.8 days. Approximately 4.1% of the company’s stock are short sold.
KraneShares MSCI All China Health Care Index ETF Stock Down 1.6%
Shares of KURE traded down $0.28 during mid-day trading on Monday, hitting $17.34. 99,421 shares of the company traded hands, compared to its average volume of 52,323. KraneShares MSCI All China Health Care Index ETF has a 1-year low of $14.38 and a 1-year high of $19.93. The company has a market capitalization of $106.64 million, a PE ratio of 24.69 and a beta of 0.24. The business has a 50 day moving average of $18.48 and a 200 day moving average of $17.48.
Institutional Inflows and Outflows
A hedge fund recently bought a new position in KraneShares MSCI All China Health Care Index ETF stock. Trek Financial LLC purchased a new position in KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 819,686 shares of the company’s stock, valued at approximately $15,779,000. Trek Financial LLC owned about 13.33% of KraneShares MSCI All China Health Care Index ETF at the end of the most recent quarter.
About KraneShares MSCI All China Health Care Index ETF
The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.
Further Reading
- Five stocks we like better than KraneShares MSCI All China Health Care Index ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for KraneShares MSCI All China Health Care Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KraneShares MSCI All China Health Care Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
